Wiley

The Wiley DEAL enables scientists at all EMBL sites to publish Open Access for free (in hybrid/open coice journals) or with 20% discount (in full Open Access journals) and grants access to the entire journal portfolio of Wiley (since 1997).

Elsevier

Researchers affiliated to EMBL can benefit from reading access to almost the entire Elsevier journal portfolio, including the Cell Press and The Lancet titles, and publish Open Access for free (Hybrid) or with a 20% discount (fully Open Access journals). 

Springer Nature

The Springer Nature DEAL enables scientists at all EMBL sites to publish Open Access for free (Hybrid/Open Access journals) or with 20% discount (full Open Access journals) in more than 2.300 journals and grants access to almost the entire journal portfolio of Springer Nature.

Nature Portfolio journals:

EMBL authors can publish their accepted primary research articles gold OA in Nature and in 32 Nature research journals, published monthly, across the life, physical, clinical and social sciences. All EMBL users gain reading access to the complete Nature portfolio, including 21 Nature Reviews titles and also all forthcoming new journals from the Nature Portfolio. 

American Chemical Society

The ACS Read and Publish deal runs from 1 Jan 2024 though 31 December 2026. Corresponding authors from all six EMBL sites can publish their work in more than 80 hybrid and fully Open Access ACS journals under a CC BY licence without paying individual APCs. Please note the journals not included in the publishing part of the deal: Artificial Photosynthesis, Chem & Bio Engineering, Chemical & Biomedical Imaging, Environment & Health, Precision Chemistry.

Frontiers

With our institutional membership, EMBL affiliated authors will receive a 10% discount on the article processing charge for publishing in any Frontiers journal.

The Company of Biologists

The Publish and Read Agreement with The Company of Biologists (available from 2021) grants EMBL researchers unlimited access to Development, Journal of Cell Science, and Journal of Experimental Biology including perpetual access to content dating back to 1853. Moreover, it allows unlimited fee-free Open Access publishing of research articles for corresponding authors, with authors retaining copyright.

Royal Society of Chemistry

“Read & Publish” is a combined licensing model that combines the use of RSC journals and the possibility to publish Open Access.
Read component: through this agreement, all six EMBL sites have access to 37 current RSC hybrid journals.
Publish component: Corresponding authors from all six EMBL sites can publish their work in the hybrid journals under a CC BY licence without paying APCs. In addition, corresponding authors from all six EMBL sites receive a 15% discount on the APC fee for publications in RSC fully open access journals.

Institute of Physics (IOP)

The IOP Read and Publish agreement offers access to over 85 IOP journals. In addition to the subscription, the licence model includes an extensive publish component: The licence fee covers the cost of an unlimited number of articles that can be published without embargo period and under CC BY 4.0 licence in 53 hybrid journals and 19 Gold Open Access journals of IOP.

Rockefeller University Press (RUP)

The RUP read and publish agreement offers unlimited access to all content published in RUP’s three hybrid journals: Journal of Cell Biology (JCB), Journal of Experimental Medicine (JEM),and Journal of General Physiology (JGP).
Research articles by corresponding authors from all six EMBL sites are published Open Access under a CC-BY license, without additional open access fees.

Microbiology Society

The Microbiology Society’s ’Publish and Read’ deal will allow EMBL researchers to publish an unlimited number of open-access articles (OA) and provides unrestricted access to the Society’s journal portfolio. Submitting authors will be eligible for fee-free OA.

Publish and Read will be across all the Society’s six journals including Microbiology, Journal of General Virology, Journal of Medical Microbiology, Microbial Genomics, International Journal of Systematic and Evolutionary Microbiology and Access Microbiology.

The Royal Society

Authors affiliated to EMBL receive a 25% discount on the article processing charge for publishing in any journal of The Royal Society.

PNAS

Immediate Open Access APC: $4,975 for a regular research article for authors from institutions with a site license.

Portland Press

Portland Press approves approx. 15% discount when publishing in Biochemical Journal, Clinical Science, Biochemical Society Transactions and Essays in Biochemistry.

IUCr journals

15% reduction in the APCs when publishing in a fully Open Access IUCr journal (Acta Cryst. E, IUCrData and IUCrJ).

Article Processing Charges for all IUCr hybrid journals (Acta Cryst. A, B, C, D and F, J Appl Crystallogr and J Synchrotron Radiat) are fully covered by the Wiley DEAL agreement (see above).

PLOS

The EMBL Szilárd Library pays an annual flat fee to finance EMBL researchers’ publications in all 12 of the publisher’s journals – there is no upper article limit. Researchers of all six EMBL sites are eligible.
This is possible because the EMBL Szilárd Library participates in a consortial open access framework agreement with PLOS (contract years 2023-2024), which includes publication services from the non-profit publisher Public Library of Science (PLOS), which exclusively publishes pure open access journals in the natural and life sciences and related disciplines.